Cephacare flavour 1000 mg tablets for dogs

Cross-resistance has been shown between cephalosporins and penicillins. Use of
cefalexin should be carefully considered when susceptibility testing has shown
resistance to penicillins because its effectiveness may be reduced.
AN: 02159/2024 & 02163/2024

Special precautions for safe use in target species:
Use of the veterinary medicinal product should be based on identification and
susceptibility testing of the target pathogen(s) isolated from the animal. If this is not
possible, therapy should be based on epidemiological information and knowledge of
susceptibility of the target pathogens at local/regional level.
Use of the veterinary medicinal product should be in accordance with official, national
and regional antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach.
Use of the veterinary medicinal product deviating from the instructions given in the
SPC may increase the prevalence of bacteria resistant to cefalexin and may
decrease the effectiveness of treatment with other beta-lactam antibiotics, due to the
potential for cross-resistance.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary
accumulation may occur in the body when renal function is impaired. In cases of
known renal insufficiency, the dose should be reduced, antimicrobials known to be
nephrotoxic should not be administered concurrently and the veterinary medicinal
product should be used only according to the benefit-risk assessment by the
responsible veterinarian.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out
of reach of the animals.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Penicillins and cephalosporins may cause hypersensitivity (allergy) following
injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead
to cross-reactions to cephalosporin and vice versa. Allergic reactions to these
substances may occasionally be serious. People with known hypersensitivity to
cefalexin should avoid contact with the veterinary medicinal product.
Handle this veterinary medicinal product with great care to avoid exposure, taking all
recommended precautions. If you develop symptoms following exposure such as
skin rash, you should seek medical advice immediately and show the package leaflet
or the label to the physician. Swelling of the face, lips or eyes or difficulty breathing
are more serious symptoms and require urgent medical attention.
To avoid accidental ingestion, particularly by a child, unused part-tablets should be
returned to the open blister space and inserted back into the outer packaging. In
case of accidental ingestion, seek medical advice immediately and show the package
leaflet or the label to the physician.
Wash hands after use.
AN: 02159/2024 & 02163/2024
Special precautions for the protection of the environment:
Not applicable.